Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Mechanisms of Cellular Crosstalk Between Mesenchymal Stem Cells and Natural Killer Cells: Therapeutic Implications Publisher Pubmed



Moloudizargari M1 ; Govahi A1 ; Fallah M2 ; Rezvanfar MA3 ; Asghari MH4 ; Abdollahi M3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Department of Pharmacology and Toxicology, Medicinal Plant Research Centre, Faculty of Pharmacy, Islamic Azad University, Amol, Iran
  3. 3. Toxicology and Diseases Group, Pharmaceutical Sciences Research Center, The Institute of Pharmaceutical Sciences (TIPS), and Department of Toxicology and Pharmacology, School of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, Iran
  4. 4. Department of Pharmacology and Toxicology, School of Medicine, Babol University of Medical Sciences, Babol, Iran

Source: Journal of Cellular Physiology Published:2021


Abstract

Mesenchymal stem cells (MSCs) are mesenchymal precursors of various origins, with well-known immunomodulatory effects. Natural killer (NK) cells, the major cells of the innate immune system, are critical for the antitumor and antiviral defenses; however, in certain cases, they may be the main culprits in the pathogenesis of some NK-related conditions such as autoimmunities and hematological malignancies. On the other hand, these cells seem to be the major responders in beneficial phenomena like graft versus leukemia. Substantial data suggest that MSCs can variably affect NK cells and can be affected by these cells. Accordingly, acquiring a profound understanding of the crosstalk between MSCs and NK cells and the involved mechanisms seems to be a necessity to develop therapeutic approaches based on such interactions. Therefore, in this study, we made a thorough review of the existing literature on the interactions between MSCs and NK cells with a focus on the underlying mechanisms. The current knowledge herein suggests that MSCs possess a great potential to be used as tools for therapeutic targeting of NK cells in disease context and that preconditioning of MSCs, as well as their genetic manipulation before administration, may provide a wider variety of options in terms of eliciting more specific and desirable therapeutic outcomes. Nevertheless, our knowledge regarding the effects of MSCs on NK cells is still in its infancy, and further studies with well-defined conditions are warranted herein. © 2020 Wiley Periodicals LLC
Other Related Docs
14. Car-Nk Cells for Haematological Cancers, Best Practice and Research: Clinical Haematology (2025)
28. Overview of Mesenchymal Stem Cells, Stem Cells in Urology (2020)
31. Nk Cells - Dr. Jekyll and Mr. Hyde in Autoimmune Rheumatic Diseases, International Immunopharmacology (2022)
34. Mesenchymal Stem Cells-Derived Exosomes for Wound Regeneration, Advances in Experimental Medicine and Biology (2018)